X-COR Therapeutics Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
X-COR Therapeutics General Information
Description
Developer of an extracorporeal CO2 removal device designed to treat acute respiratory failure. The company's device uses ultra-low-blood flow to treat patients with symptomatic lung failure with an accompanying control algorithm that is based on machine-learning techniques, enabling patients to get affordable and accessible therapy than existing comparable extracorporeal devices that often require flows and specialized physician interventions.
Contact Information
Website
www.xcortherapeutics.comCorporate Office
- 701 East Pratt Street
- Baltimore, MD 21202
- United States
Corporate Office
- 701 East Pratt Street
- Baltimore, MD 21202
- United States
X-COR Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Out of Business | 15-Sep-2025 | Completed | Out of Business | |||
| 11. Accelerator/Incubator | 01-Feb-2025 | Completed | Generating Revenue | |||
| 10. Grant | 25-Dec-2021 | Completed | Generating Revenue | |||
| 9. Seed Round | 23-Mar-2020 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 07-May-2019 | Completed | Generating Revenue | |||
| 7. Grant | 24-Apr-2019 | Completed | Generating Revenue | |||
| 6. Seed Round | 21-Feb-2019 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jun-2018 | Completed | Generating Revenue | |||
| 4. Grant | 03-May-2018 | $25K | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup |
X-COR Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 1 |
X-COR Therapeutics Patents
X-COR Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025174956-A1 | Mass transfer device for the treatment of biological fluids and methods of use | Pending | 14-Feb-2024 | ||
| EP-3681554-B1 | Systems for extracorporeal removal of carbon dioxide | Active | 17-Sep-2017 | ||
| CA-3075762-A1 | Systems, devices, and methods for extracorporeal removal of carbon dioxide | Pending | 17-Sep-2017 | ||
| EP-3681554-A2 | Systems, devices, and methods for extracorporeal removal of carbon dioxide | Active | 17-Sep-2017 | ||
| EP-3681554-A4 | Systems, devices, and methods for extracorporeal removal of carbon dioxide | Active | 17-Sep-2017 | A61M1/1698 |
X-COR Therapeutics Signals
X-COR Therapeutics FAQs
-
When was X-COR Therapeutics founded?
X-COR Therapeutics was founded in 2017.
-
Where is X-COR Therapeutics headquartered?
X-COR Therapeutics is headquartered in Baltimore, MD.
-
What is the size of X-COR Therapeutics?
X-COR Therapeutics has 2 total employees.
-
What industry is X-COR Therapeutics in?
X-COR Therapeutics’s primary industry is Therapeutic Devices.
-
Is X-COR Therapeutics a private or public company?
X-COR Therapeutics is a Private company.
-
What is X-COR Therapeutics’s current revenue?
The current revenue for X-COR Therapeutics is .
-
How much funding has X-COR Therapeutics raised over time?
X-COR Therapeutics has raised $2.8M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process